2023-12-05 · ANDA210317
Octreotide
octreotide acetate · original submission 1 · status AP.
Open full application timeline →Open selected original record →
FDA application source year
7 selected records whose approved original-submission status date falls in 2023. Dates and status codes are attributed to the retained official dataset observation.
2023-12-05 · ANDA210317
octreotide acetate · original submission 1 · status AP.
Open full application timeline →2023-11-16 · ANDA208569
teriparatide · original submission 1 · status AP.
Open full application timeline →2023-11-16 · ANDA211097
teriparatide · original submission 1 · status AP.
Open full application timeline →2023-11-08 · NDA217806
tirzepatide · original submission 1 · status AP.
Open full application timeline →2023-06-22 · ANDA216839
octreotide acetate · original submission 1 · status AP.
Open full application timeline →2023-06-13 · ANDA216807
octreotide acetate · original submission 1 · status AP.
Open full application timeline →2023-02-07 · ANDA209611
linaclotide · original submission 1 · status AP.
Open full application timeline →